SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-043391
Filing Date
2008-02-29
Accepted
2008-02-29 14:16:35
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1453808
2 SEVERANCE BENEFIT PLAN, AS AMENDED dex1015.htm EX-10.15 62460
3 TERMINATION AGREEMENT AND MUTUAL RELEASE dex1032.htm EX-10.32 33738
4 EXCLUSIVE RESEARCH, DEVELOPMENT, LICENSE AND MANUFACTURING AND SUPPLY AGREEMENT dex1033.htm EX-10.33 555455
5 SUBSIDIARIES OF NEKTAR THERAPEUTICS dex211.htm EX-21.1 3503
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2560
7 CERTIFICATION OF PEO REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 7293
8 CERTIFICATION OF PFO REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 7440
9 SECTION 1350 CERTIFICATIONS dex321.htm EX-32.1 4653
10 GRAPHIC g93225g51p59.jpg GRAPHIC 34951
  Complete submission text file 0001193125-08-043391.txt   2180805
Mailing Address 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 150 INDUSTRIAL RD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24006 | Film No.: 08654543
SIC: 2834 Pharmaceutical Preparations